Day: November 13

Industry innovation in diagnostic technologies and targeted treatment strategies drives progress in personalized medicine. But the path to market is fraught with obstacles. Pioneering investors and executives reflect on how to deal with challenges and uncertainty in an increasingly variable development and market environment. MODERATOR | Kristin Ciriello Pothier, Life Sciences Sector Leader, Global Deal Advisory […]

This session explores the cutting edge of personalized medicine beyond traditional gene testing, highlighting the clinical integration of next-generation diagnostic technologies. Experts will discuss the promise and practical application of proteomics, metagenomics, circulating tumor DNA (ctDNA), and digital diagnostic tools in delivering more precise, timely, and individualized care. MODERATOR | Yuri Fesko, M.D., Senior Vice […]

MODERATOR | Lauren Silvis, J.D., Senior Vice President, External Affairs, Tempus KEYNOTE SPEAKER | Peter Marks, M.D., Ph.D., Former Director, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration

SPEAKER | Daryl Pritchard, Ph.D., President, Personalized Medicine Coalition